G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
RESEARCH TRIANGLE PARK, N.C., Jan. 02, 2024 (GLOBE NEWSWIRE) — G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, today […]
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
NEW YORK and SAN DIEGO, Jan. 02, 2024 (GLOBE NEWSWIRE) — Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company […]
Pennant and John Muir Health Enter into a Home Health Joint Venture in the Bay Area, California
EAGLE, Idaho, Jan. 02, 2024 (GLOBE NEWSWIRE) — The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant […]
Apollomics to Present at the 2024 Biotech Showcase
FOSTER CITY, Calif., Jan. 02, 2024 (GLOBE NEWSWIRE) — Apollomics Inc. (“Apollomics” or the “Company”), a clinical-stage biopharmaceutical company developing […]
O’Reilly Automotive, Inc. Announces Dates for Its Fourth Quarter and Full-Year 2023 Earnings Release and Conference Call
Earnings Release Date – Wednesday, February 7, 2024, after 3:30 p.m. Central Time Conference Call Date – Thursday, February 8, […]
IRADIMED CORPORATION To Present at the 42nd Annual J.P. Morgan Healthcare Conference
WINTER SPRINGS, Fla., Jan. 02, 2024 (GLOBE NEWSWIRE) — IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD), a leader in developing innovative […]
Covenant Logistics Group, Inc. Announces Timing of Fourth Quarter Earnings Release and Conference Call
CHATTANOOGA, Tenn., Jan. 02, 2024 (GLOBE NEWSWIRE) — Covenant Logistics Group, Inc. (Nasdaq/GS: CVLG) announced its plans to release its […]
SAB Biotherapeutics Announces 1-for-10 Reverse Stock Split
SIOUX FALLS, S.D., Jan. 02, 2024 (GLOBE NEWSWIRE) — SAB Biotherapeutics, Inc. (Nasdaq: SABS), a clinical-stage biopharmaceutical company with a novel […]
Lands’ End Announces Participation in the 26th Annual ICR Conference
DODGEVILLE, Wis., Jan. 02, 2024 (GLOBE NEWSWIRE) — Lands’ End, Inc. (NASDAQ: LE) today announced that the Company will be […]
ORIC Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Jan. 02, 2024 (GLOBE NEWSWIRE) — ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical […]
